Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000753a ACVR2A
Assay data:1 Tested
SummaryRelated BioAssays by Target
ACVR2A DiscoveRx kinase panel
ACVR2B DiscoveRx kinase panel
Inhibition of ACV-R2B (unknown origin) assessed as residual activity at 1 uM
SummaryPubMed CitationRelated BioAssays by Target
KinomeScan assay: inhibition of ACVR2B
Assay data:108 Tested
KinomeScan assay: inhibition of ACVR2A
Assay data:1 Active, 108 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
ACtR2(AC2ALGE1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
ACVR2B Kinase screen
ACVR2B Invitrogen selectivity data (BI)
ACVR2B Invitrogen Lab (UK) kinase screen (BI)
ACVR2A Invitrogen Lab (UK) kinase screen (BI)
ACVR2B Kinase panel
Inhibition of ACVR2B (unknown origin) assessed as residual activity measured at 1 uM
Assay data:3 Tested
Inhibition of ACVR2A (unknown origin) assessed as residual activity measured at 1 uM
Inhibition of ACVR2A (unknown origin) assessed as residual activity at 1 uM
Assay data:2 Tested
Inhibition of human ACVR2B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of human ACVR2A assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on